Abbvie Inc Stock Performance
as on April 9, 2026 at 6:59 am IST
Day's Low
Day's High
$204.56$212.22
3.38%
Downside
0.24%
Upside
52 Week's Low
52 Week's High
$164.39$244.8122.35%
Downside
15.63%
Upside
Abbvie Inc share price movements today
- Previous Close
- $206.37
- Open
- $206.00
- Volume
- 3.0M
- Day's Low - High
- $204.56 - $212.22
- 52 Week Low - High
- $164.39 - $244.81
Abbvie Inc Historical Returns
- 1 Month Return
- -10.32 %
- 3 Month Return
- -7.92 %
- 1 Year Return
- + 17.48 %
- 3 Year Return
- + 27.74 %
- 5 Year Return
- + 94.51 %
Abbvie Inc Stock Fundamentals & Key Indicators
Check Abbvie Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$365.6B
EPS (TTM)
14.5364
Dividend Yield
3.10%
Quarterly Earnings Growth YOY
-0.89%
PE Ratio (TTM)
87.58
Industry PE ratio
26.88111111111111
PEG Ratio
0.4949
EBITDA
29.3B
Revenue (TTM)
61.2B
Profit Margin
6.91%
Return On Equity TTM
62.25%
Abbvie Inc Stock Valuation
Track how Abbvie Inc P/E has moved over time to understand its valuation trends.
Abbvie Inc in the last 5 years
Lowest (9.30x)
September 30, 2021
Industry (26.88x)
April 8, 2026
Today (87.58x)
April 8, 2026
Highest (22.78x)
December 31, 2025
Today’s Price to Earnings Ratio: 87.58x
Abbvie Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Abbvie Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $365.6B | 94.51% | 87.58 | 6.91% | |
| BUY | $314.4B | 305.68% | 31.06 | 17.41% | |
| BUY | $833.3B | 409.88% | 40.5 | 31.67% | |
| BUY | $580.7B | 46.29% | 21.85 | 28.46% | |
| BUY | $298.8B | 58.01% | 16.6 | 28.08% |
Stock Returns calculator for Abbvie Inc Stock including INR - Dollar returns
The Abbvie Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Abbvie Inc investment value today
Current value as on today
₹1,29,026
Returns
₹29,026
(+29.03%)
Returns from Abbvie Inc Stock
₹20,521 (+20.52%)
Dollar Impact
₹8,504 (+8.5%)
Analyst Recommendation on Abbvie Inc Stock
Based on 35 analysts
65.71%
Buy
34.29%
Hold
0.00%
Sell
Based on 35 analysts, 65.71% of analysts recommend a 'BUY' rating for Abbvie Inc. Average target price of $249.14
Abbvie Inc Share Price Target
Get share price movements and forecasts by analysts on Abbvie Inc.
What analysts predicted
15.02%UPSIDE
Target Price
$249.14
Current Price
$211.72
Analyzed by
35 Analysts
Target
$249.14
Abbvie Inc target price $249.14, a slight upside of 15.02% compared to current price of $211.72. According to 35 analysts rating.
Abbvie Inc Stock’s Investor Sentiment and Interest
Investment in Abbvie Inc Shares on INDmoney has grown by 17.56% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:17.56% versus previous 30 day period
Search interest for Abbvie Inc Stock has decreased by -28% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Abbvie Inc Quarterly Profit & Loss
All numbers in Millions USD
Abbvie Inc Annual Profit & Loss
All numbers in Millions USD
Abbvie Inc Quarterly Cash Flow
All numbers in Millions USD
Abbvie Inc Annual Cash Flow
All numbers in Millions USD
Mutual Funds that own Abbvie Inc Stock
Check out the Mutual Funds with significant holdings in Abbvie Inc.
Funds | Holdings | Shares Held |
|---|---|---|
 Motilal Oswal S&P 500 Index Fund Direct Growth | 0.68915% | 13229 |
 Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth | 2.90932% | 2411 |
Global Institutional Holdings in Abbvie Inc
Abbvie Inc News & Key Events
Today's Timeline - 08 April
Wed, 10:39 AM
-AbbVie showcases new dermatology research, highlighting potential revenue growth and FDA updates for Skyrizi.
Wed, 09:47 PM
-AbbVie files lawsuit seeking clearer guidance on 340B drug discount eligibility to address program abuses.
Thu, 00:35 AM
-Analysts express mixed views on AbbVie’s immunology pipeline amid valuation concerns and price target adjustments.
Insights on Abbvie Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Abbvie Inc has shown consistent revenue growth over the last four quarters. The company's revenue increased from $13.34 billion to $16.61 billion, reflecting an average growth rate of 6.9% per quarter.
- POSITIVE IMPACT
Profit Spike
Abbvie Inc has shown impressive growth in its net profit over the last two quarters. It increased from $186.0 million to $1.81 billion, which translates to an average quarterly growth rate of 89.8%. This indicates strong financial performance and positive trends in profitability for the company.
NO EFFECTAgainst Peers
In the last 1 year, ASTRAZENECA PLC has given 209.4% return, outperforming this stock by 191.9%
- NO EFFECT
Against Peers
In the last 3 years, ASTRAZENECA PLC has given 177.6% return, outperforming this stock by 149.9%
NEGATIVE IMPACTPrice Dip
In the last 7 days, ABBV stock has moved down by -4.0%
About Abbvie Inc
| Organisation | Abbvie Inc |
| Headquarters | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 |
| Industry | Health Technology |
| CEO | Mr. Robert A. Michael CPA |
| E-voting on shares | Click here to vote |
Key Management of Abbvie Inc
Name | Title |
|---|---|
Mr. Robert A. Michael CPA | CEO & Chairman of the Board |
Mr. Scott T. Reents | Executive VP & CFO |
Dr. Azita Saleki-Gerhardt Ph.D. | Executive VP & COO |
Mr. Jeffrey Ryan Stewart | Executive VP & Chief Commercial Officer |
Ms. Linda Ray | Senior VP & Chief Information Officer |
Mr. Demetris D. Crum | Executive VP & Chief Human Resources Officer |
Dr. Roopal B. Thakkar M.D. | Executive VP of Research & Development and Chief Scientific Officer |
Ms. Elizabeth Shea | Senior Vice President of Investor Relations |
Mr. Perry C. Siatis | Executive VP, General Counsel & Secretary |
Mr. Wulff-Erik von Borcke | Senior VP & President of Oncology |
FAQs
What is Abbvie Inc share price today?
Abbvie Inc share price today is $211.72 as on at the close of the market. Abbvie Inc share today touched a day high of $212.22 and a low of $204.56.
What is the 52 week high and 52 week low for Abbvie Inc share?
Abbvie Inc share touched a 52 week high of $244.81 on and a 52 week low of $164.39 on . Abbvie Inc stock price today i.e. is closed at $211.72,which is 13.52% down from its 52 week high and 28.79% up from its 52 week low.
What is Abbvie Inc's market capitalisation today?
Abbvie Inc market capitalisation is $0.37T as on .
How to invest in Abbvie Inc Stock (ABBV) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Abbvie Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Abbvie Inc Shares that will get you 0.0071 shares as per Abbvie Inc share price of $211.72 per share as on April 9, 2026 at 1:29 am IST.
What is the minimum amount required to buy Abbvie Inc Stock (ABBV) from India?
Indian investors can start investing in Abbvie Inc (ABBV) shares with as little as ₹92.336 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹923.36 in Abbvie Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Abbvie Inc share’s latest price of $211.72 as on April 9, 2026 at 1:29 am IST, you will get 0.0472 shares of Abbvie Inc. Learn more about
fractional shares .
What are the returns that Abbvie Inc has given to Indian investors in the last 5 years?
Abbvie Inc stock has given 94.51% share price returns and 24.79% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?